BAL联合CT鉴别进行性与非进行性纤维化肺疾病
研究探索基线BAL淋巴细胞比例联合CT纤维化 extent和UIP模式区分进行性与非进行性肺纤维化。衍生队列240例,验证队列290例,进行性定义年化FVC下降>10%或1年内死亡。BAL淋巴细胞比例、UIP模式、纤维化extent独立相关,阈值分别为25%和20%。
要点
- BAL淋巴细胞比例≥25%与较低进展概率相关,尤其非UIP或局限纤维化者。
- UIP模式或广泛纤维化(extent>20%)患者BAL淋巴细胞增多罕见。
- 联合BAL与CT有助识别肺纤维化进展低风险患者。
核心结论
- 广泛纤维化或UIP模式患者BAL淋巴细胞增多罕见。
- 非UIP或局限纤维化者BAL淋巴细胞比例≥25%与较低进展概率相关。
研究设计与样本
- 衍生队列为诊断性检查中行BAL的初发PF病例(n=240)。
- 验证队列前瞻性招募,纳入标准相同(n=290)。
- 基线CT评估纤维化extent和UIP模式,记录BAL淋巴细胞比例。
主要发现
- BAL淋巴细胞比例、UIP模式、纤维化extent独立与疾病进展相关(衍生队列)。
- BAL淋巴细胞比例增高和广泛纤维化的二元阈值分别为25%和20%。
- UIP模式患者BAL淋巴细胞增多8/135(5.9%),广泛纤维化者7/144(4.9%)。
- 验证队列中,非广泛纤维化或非UIP模式者BAL淋巴细胞比例增高与进展概率显著降低相关。
关键数值与推荐
- 疾病进展定义:年化FVC下降>10%或1年内死亡。
- BAL淋巴细胞比例增高阈值:25%。
- CT广泛纤维化阈值:20%。
临床怎么用
- 对非UIP模式或局限纤维化PF患者,可参考BAL淋巴细胞比例≥25%识别进展低风险。
- UIP模式或广泛纤维化患者BAL淋巴细胞增多少见,联合CT与BAL有助管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Identifying patients with pulmonary fibrosis (PF) at risk of progression can guide management. Objectives: To explore the utility of combining baseline BAL and computed tomography (CT) in differentiating progressive and nonprogressive PF. Methods: The derivation cohort consisted of incident cases of PF for which BAL was performed as part of a diagnostic workup. A validation cohort was prospectively recruited with identical inclusion criteria. Baseline thoracic CT scans were scored for the extent of fibrosis and usual interstitial pneumonia (UIP) pattern. The BAL lymphocyte proportion was recorded. Annualized FVC decrease of >10% or death within 1 year was used to define disease progression. Multivariable logistic regression identified the determinants of the outcome. The optimum binary thresholds (maximal Wilcoxon rank statistic) at which the extent of fibrosis on CT and the BAL lymphocyte proportion could distinguish disease progression were identified. Measurements and Main Results: BAL lymphocyte proportion, UIP pattern, and fibrosis extent were significantly and independently associated with disease progression in the derivation cohort (n = 240). Binary thresholds for increased BAL lymphocyte proportion and extensive fibrosis were identified as 25% and 20%, respectively. An increased BAL lymphocyte proportion was rare in patients with a UIP pattern (8 of 135; 5.9%) or with extensive fibrosis (7 of 144; 4.9%). In the validation cohort (n = 290), an increased BAL lymphocyte proportion was associated with a significantly lower probability of disease progression in patients with nonextensive fibrosis or a non-UIP pattern. Conclusions: BAL lymphocytosis is rare in patients with extensive fibrosis or a UIP pattern on CT. In patients without a UIP pattern or with limited fibrosis, a BAL lymphocyte proportion of ⩾25% was associated with a lower likelihood of progression.
引用
- Barnett JL, Maher TM, Quint JK, et al. Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases. Am J Respir Crit Care Med. 2023. PMID: 37672028. doi:10.1164/rccm.202305-0796OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。